Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop...
By I. Edwards HealthDay Reporter
WEDNESDAY, June 18, 2025 (HealthDay News) — Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about...
New COVID Variant, NB.1.8.1, May Now Make Up 1 in 3 U.S. Cases
By I. Edwards HealthDay Reporter
MONDAY, June 16, 2025 (HealthDay News) — A new COVID-19 variant that led to a spike in hospital cases across...
Circulating Tumor DNA Can Be Detected Several Years Before Cancer Diagnosis
Same mutations detected by the multicancer early detection test at index time point could be ID'd at 8.6- to 79-fold lower mutant allele fractions
Childhood Cancer Treatment, Genetics Contribute to Subsequent Neoplasm Risk
Contributions quantified for subsequent neoplasms in childhood cancer survivors
More Than 460 CDC Workers Reinstated After Layoffs
By I. Edwards HealthDay Reporter
FRIDAY, June 13, 2025 (HealthDay News) — More than 460 laid-off employees at the U.S. Centers for Disease Control and...
Blood-Based Screening Has Acceptable Accuracy for Colorectal Cancer Detection
In an average-risk colorectal cancer screening population, a blood-based circulating tumor DNA test is feasible
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
Shorter leukocyte telomere length linked to higher incidence rates of stroke, dementia, late-life depression as composite and individually
RFK Jr. Installs Critics on Vaccine Recommendation Panel
By Carole Tanzer Miller HealthDay Reporter
THURSDAY, June 12, 2025 (HealthDay News) — Days after ousting all 17 members of the panel that makes U.S....
Mailed Self-Collection Kits Increase Rates of Cervical Cancer Screening
Findings seen compared with telephone reminders for women overdue for screening in a safety-net setting
FDA Plans to Use AI to Speed Up Drug and Food Safety Reviews
By I. Edwards HealthDay Reporter
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial...